Short-term outcomes of intravitreal faricimab for treatment-naive neovascular age-related macular degeneration. Matsumoto H, Hoshino J, Nakamura K, Nagashima T, et al. Graefes Arch Clin Exp Ophthalmol 2023 May 17. doi: 10.1007/s00417-023-06116.

Read + Share

Amedeo Smart

Independent Medical Education

Matsumoto H, Hoshino J, Nakamura K, Nagashima T, et al. Short-term outcomes of intravitreal faricimab for treatment-naive neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2023 May 17. doi: 10.1007/s00417-023-06116.
PMID: 37195339